	Ebitda		Date
AbbVie	USD 3.52B	828M	2025-09
Amgen	USD 5.14B	775M	2025-12
Anika Therapeutics	USD -2.69M	4.73M	2025-03
Arrowhead Research	USD 64.2M	223.53M	2025-09
AstraZeneca	USD 5.23B	272M	2025-09
Biogen	USD 573.2M	253.7M	2025-12
Bristol-Myers Squibb	USD 4.24B	967M	2025-09
Gilead Sciences	USD 4.03B	628M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Halozyme Therapeutics	USD 248.25M	22.74M	2025-09
Heron Therapeutics	USD -3.88M	5.63M	2024-09
Immunic	USD -22.78M	753K	2024-06
Incyte	USD 506.92M	74.6M	2025-09
Insmed	USD -297.13M	71.11M	2025-06
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
J&J	USD 9.52B	389M	2025-09
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
Ligand Pharmaceuticals	USD 20.9M	61.44M	2025-06
Merck	USD 8.39B	1.97B	2025-09
Neurocrine Biosciences	USD 246.7M	93.8M	2025-09
Novartis	USD 5.88B	290M	2025-09
Novavax	USD -117.12M	55.66M	2024-09
Pfizer	USD 6.08B	351M	2025-09
PTC Therapeutics	USD -33.11M	1B	2025-06
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD 126.42M	416.82M	2025-06
Vertex Pharmaceuticals	USD 1.44B	100.4M	2025-09

Enanta Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.